BRAoVO™ Genetic Testing & Counselling Package (GP Request)

Test description

Some families may have an increased risk of developing certain types of cancer through the inheritance of harmful changes (pathogenic variants) in certain genes.

Testing for these genetic variants can determine whether a patient might be at increased risk of developing cancer and suggest an appropriate prevention or surveillance strategy.

The genes analysed in this panel, ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53, are all high and medium high risk genes for breast and/or ovarian cancer.

Pre-test genetic counselling session
Genetic testing of 13 high and medium high risk genes – ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53
Post-test genetic counselling session

Test information

Test name

BRAoVO™ Genetic Testing & Counselling Package (GP Request)

‍

Clinical indication

To determine presence or absence of germline variant for hereditary breast and ovarian cancer

Gene(s)

ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53

Method

Massively Parallel Sequencing

Turn around time

Including two counselling sessions, 7 - 9 weeks

Medicare eligibility

Price

$899

Test request form

Cancer genetics request form - GP Only preferred. Standard pathology form accepted.

Sample type

Blood

Collection type

2 x 6mL EDTA

‍

Special instructions

Pre- and post-test genetic counselling is mandatory and included in the package.